4ibr

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (15:19, 20 September 2023) (edit) (undo)
 
(5 intermediate revisions not shown.)
Line 1: Line 1:
-
{{STRUCTURE_4ibr| PDB=4ibr | SCENE= }}
 
-
===Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S/E104K mutations===
 
-
{{ABSTRACT_PUBMED_23542341}}
 
-
==Function==
+
==Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S/E104K mutations==
-
[[http://www.uniprot.org/uniprot/BLAT_ECOLX BLAT_ECOLX]] TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.
+
<StructureSection load='4ibr' size='340' side='right'caption='[[4ibr]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[4ibr]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4IBR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4IBR FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ibr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ibr OCA], [https://pdbe.org/4ibr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ibr RCSB], [https://www.ebi.ac.uk/pdbsum/4ibr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ibr ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/BLAT_ECOLX BLAT_ECOLX] TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Protein evolvability includes two elements-robustness (or neutrality, mutations having no effect) and innovability (mutations readily inducing new functions). How are these two conflicting demands bridged? Does the ability to bridge them relate to the observation that certain folds, such as TIM barrels, accommodate numerous functions, whereas other folds support only one? Here, we hypothesize that the key to innovability is polarity-an active site composed of flexible, loosely packed loops alongside a well-separated, highly ordered scaffold. We show that highly stabilized variants of TEM-1 beta-lactamase exhibit selective rigidification of the enzyme's scaffold while the active-site loops maintained their conformational plasticity. Polarity therefore results in stabilizing, compensatory mutations not trading off, but instead promoting the acquisition of new activities. Indeed, computational analysis indicates that in folds that accommodate only one function throughout evolution, for example, dihydrofolate reductase, &gt;/=60% of the active-site residues belong to the scaffold. In contrast, folds associated with multiple functions such as the TIM barrel show high scaffold-active-site polarity (~20% of the active site comprises scaffold residues) and &gt;2-fold higher rates of sequence divergence at active-site positions. Our work suggests structural measures of fold polarity that appear to be correlated with innovability, thereby providing new insights regarding protein evolution, design, and engineering.
-
==About this Structure==
+
What Makes a Protein Fold Amenable to Functional Innovation? Fold Polarity and Stability Trade-offs.,Dellus-Gur E, Toth-Petroczy A, Elias M, Tawfik DS J Mol Biol. 2013 Mar 28. pii: S0022-2836(13)00200-3. doi:, 10.1016/j.jmb.2013.03.033. PMID:23542341<ref>PMID:23542341</ref>
-
[[4ibr]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Gracixalus_waza Gracixalus waza]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4IBR OCA].
+
-
==Reference==
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
<ref group="xtra">PMID:023542341</ref><references group="xtra"/><references/>
+
</div>
-
[[Category: Beta-lactamase]]
+
<div class="pdbe-citations 4ibr" style="background-color:#fffaf0;"></div>
-
[[Category: Gracixalus waza]]
+
 
-
[[Category: Dellus-Gur, E.]]
+
==See Also==
-
[[Category: Elias, M.]]
+
*[[Beta-lactamase 3D structures|Beta-lactamase 3D structures]]
-
[[Category: Tawfik, D S.]]
+
== References ==
-
[[Category: Toth-Petroczy, A.]]
+
<references/>
-
[[Category: Beta-lactamase]]
+
__TOC__
-
[[Category: Hydrolase]]
+
</StructureSection>
 +
[[Category: Escherichia coli]]
 +
[[Category: Large Structures]]
 +
[[Category: Dellus-Gur E]]
 +
[[Category: Elias M]]
 +
[[Category: Tawfik DS]]
 +
[[Category: Toth-Petroczy A]]

Current revision

Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying G238S/E104K mutations

PDB ID 4ibr

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools